BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33198557)

  • 1. RGS12 Represses Oral Cancer via the Phosphorylation and SUMOylation of PTEN.
    Fu C; Yuan G; Yang ST; Zhang D; Yang S
    J Dent Res; 2021 May; 100(5):522-531. PubMed ID: 33198557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulator of G Protein Signaling Protein 12 (Rgs12) Controls Mouse Osteoblast Differentiation via Calcium Channel/Oscillation and Gαi-ERK Signaling.
    Li Z; Liu T; Gilmore A; Gómez NM; Fu C; Lim J; Yang S; Mitchell CH; Li YP; Oursler MJ; Yang S
    J Bone Miner Res; 2019 Apr; 34(4):752-764. PubMed ID: 30489658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS12 represses oral squamous cell carcinoma by driving M1 polarization of tumor-associated macrophages via controlling ciliary MYCBP2/KIF2A signaling.
    Yuan G; Yang S; Yang S
    Int J Oral Sci; 2023 Feb; 15(1):11. PubMed ID: 36797232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling.
    Li Y; Liu M; Yang S; Fuller AM; Karin Eisinger-Mathason TS; Yang S
    Oncogene; 2021 Apr; 40(14):2553-2566. PubMed ID: 33686240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
    Wang X; Chen Q
    BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.
    Yuan X; Cao J; Liu T; Li YP; Scannapieco F; He X; Oursler MJ; Zhang X; Vacher J; Li C; Olson D; Yang S
    Cell Death Differ; 2015 Dec; 22(12):2046-57. PubMed ID: 25909889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the regulator of G-protein signaling 2 on the proliferation and invasion of oral squamous cell carcinoma cells and its molecular mechanism.
    Lin CZ; Liu ZQ; Zhou WK; Ji T; Cao W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Jun; 39(3):320-327. PubMed ID: 34041882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.
    Tamura T; Ichikawa T; Nakahata S; Kondo Y; Tagawa Y; Yamamoto K; Nagai K; Baba T; Yamaguchi R; Futakuchi M; Yamashita Y; Morishita K
    Cancer Res; 2017 May; 77(9):2363-2374. PubMed ID: 28209617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mx1-cre mediated Rgs12 conditional knockout mice exhibit increased bone mass phenotype.
    Yang S; Li YP; Liu T; He X; Yuan X; Li C; Cao J; Kim Y
    Genesis; 2013 Mar; 51(3):201-9. PubMed ID: 23349096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for Regulator of G protein Signaling-12 (RGS12) in the balance between myoblast proliferation and differentiation.
    Schroer AB; Mohamed JS; Willard MD; Setola V; Oestreich E; Siderovski DP
    PLoS One; 2019; 14(8):e0216167. PubMed ID: 31408461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis.
    Zeng B; Li Y; Jiang F; Wei C; Chen G; Zhang W; Zhao W; Yu D
    Exp Cell Res; 2019 Jan; 374(2):365-373. PubMed ID: 30576678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
    Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X
    Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Gαi activity by Gβγ is mediated by PI 3-kinase-γ- and cSrc-dependent tyrosine phosphorylation of Gαi and recruitment of RGS12.
    Huang J; Nalli AD; Mahavadi S; Kumar DP; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G802-10. PubMed ID: 24578342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN deficiency contributes to the development and progression of head and neck cancer.
    Squarize CH; Castilho RM; Abrahao AC; Molinolo A; Lingen MW; Gutkind JS
    Neoplasia; 2013 May; 15(5):461-71. PubMed ID: 23633918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression.
    Wang Y; Wang J; Zhang L; Karatas OF; Shao L; Zhang Y; Castro P; Creighton CJ; Ittmann M
    Cancer Res; 2017 Aug; 77(16):4247-4257. PubMed ID: 28611045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage regulator of G-protein signaling 12 contributes to inflammatory pain hypersensitivity.
    Yuan G; Yang S; Gautam M; Luo W; Yang S
    Ann Transl Med; 2021 Mar; 9(6):448. PubMed ID: 33850845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterotrimeric G-protein alpha-12 (Gα12) subunit promotes oral cancer metastasis.
    Gan CP; Patel V; Mikelis CM; Zain RB; Molinolo AA; Abraham MT; Teo SH; Abdul Rahman ZA; Gutkind JS; Cheong SC
    Oncotarget; 2014 Oct; 5(20):9626-40. PubMed ID: 25275299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
    Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
    Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4NQO induced carcinogenesis: A mouse model for oral squamous cell carcinoma.
    Sagheer SH; Whitaker-Menezes D; Han JYS; Curry JM; Martinez-Outschoorn U; Philp NJ
    Methods Cell Biol; 2021; 163():93-111. PubMed ID: 33785171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.